Clinical Trial

Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2024 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
1. Current research has found that tDCS has a positive effect on improving the negative attention bias of AD patients, and this study uses HD-tDCS intervention to improve the cognitive function and neural mechanisms of AD patients in the OFC to provide a theoretical basis for AD neural mechanism research. Verify Hypothesis 1: HD-tDCS cathodal stimulation of the left OFC reduces the excitability of this region, modulates its connectivity with the attentional function network, and thus changes the emotional experience of social threat. 2. Currently, there is no consensus on the stimulation parameters for tDCS in the treatment of AD, and more evidence is needed to prove and explore. It is hoped that the HD-tDCS intervention protocol will become an effective treatment method for improving cognitive function and clinical symptoms in AD patients. Hypothesis 2: The HD-tDCS with intensified stimulation parameters (2mA, twice a day, with a 20-minute interval, for 5 consecutive days) has an impact on the main and secondary clinical variables of AD patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06529341
Lead Sponsor Nanjing Medical University
Conditions Anxiety Disorders, High-definition Transcranial Direct Current Stimulation
Enrollment 60 participants
Start Date 2024-07-30
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-31